Key Developments: WebMD Health Corp (WBMD.OQ)

WBMD.OQ on NASDAQ Stock Exchange Global Select Market

39.06USD
24 Dec 2014
Price Change (% chg)

$-0.44 (-1.11%)
Prev Close
$39.50
Open
$39.46
Day's High
$39.85
Day's Low
$39.02
Volume
54,858
Avg. Vol
186,588
52-wk High
$53.30
52-wk Low
$34.54

Search Stocks

Latest Key Developments (Source: Significant Developments)

Webmd Health Corp Announces Pricing of $300 Million of 1.50% Convertible Notes Due 2020
Thursday, 21 Nov 2013 07:30am EST 

Webmd Health Corp announced the pricing of its private placement of $300 million aggregate principal amount of 1.50% Convertible Notes due 2020. WebMD has also granted the initial purchaser in the offering a 30-day option to purchase up to an additional $50 million aggregate principal amount of notes. WebMD intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include acquisitions, repurchases of WebMD common stock, and working capital.  Full Article

Webmd Health Corp Announces Proposed Offering of Convertible Notes
Wednesday, 20 Nov 2013 04:09pm EST 

Webmd Health Corp announced that it intends to offer $300 million of Convertible Notes due 2020 in a private placement. WebMD also expects to grant the initial purchaser in the proposed offering an option to purchase up to an additional $50 million aggregate principal amount of notes. The notes are being offered only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The notes will be convertible into shares of WebMD's common stock, based on a conversion rate to be determined. Interest on the notes will be payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2014. The notes will mature on December 1, 2020 unless previously repurchased or converted in accordance with their terms prior to such date. The interest rate, conversion rate, conversion price and other terms of the notes will be determined at the time of pricing of the offering. WebMD intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include acquisitions and repurchases of WebMD common stock, and for working capital.  Full Article

Webmd Health Corp Acquires Avado, Inc.
Tuesday, 29 Oct 2013 04:00pm EDT 

WebMD Health Corp. announced that it has acquired Avado, Inc., a developer of cloud-based patient relationship management (PRM) tools and technologies that enable better communication between consumers and health care professionals.  Full Article

Webmd Health Corp Issues Q4 2013 Revenue, Net Income Guidance In Line with Analysts' Estimates; Q4 2013 EBITDA Guidance Above Analysts' Estimates; Raises FY 2013 Guidance
Tuesday, 29 Oct 2013 04:00pm EDT 

Webmd Health Corp increased its revenue and earnings guidance for fiscal 2013 based on year-to-date actual results and its expectations for continued momentum in its public portals advertising business in the fourth quarter of 2013. For the fourth quarter of 2013, it expects revenue to be in excess of $141 million, Adjusted EBITDA to be in excess of $36 million, and Net income to be in excess of $7.7 million. For fiscal 2013 it expects Revenue to be in excess of $510 million, Adjusted EBITDA to be in excess of $118 million, and Net income to be in excess of $12 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $142 million, EBITDA of $34 million and Net income of $8.36 million for fourth quarter of 2013. revenue of $511 million, EBITDA of $114 million and Net income of $12.77 million for fiscal 2013.  Full Article

Webmd Health Corp Announces Repurchase Of Shares From Icahn Group
Monday, 21 Oct 2013 07:10am EDT 

WebMD Health Corp announced that it has entered into an agreement to repurchase all of the shares of WebMD common stock beneficially owned by Carl C. Icahn and certain of his affiliates, at a purchase price of $32.08 per share, the NASDAQ Official Closing Price of WebMD's common stock on October 18, 2013. The total purchase price for the approximately 5.5 million shares will be $177.3 million and will be funded from WebMD's cash and cash equivalents on hand. This transaction is expected to be completed today.  Full Article

Webmd Health Corp Announces Preliminary Results Of Tender Offer
Wednesday, 11 Sep 2013 07:00am EDT 

Webmd Health Corp announced the preliminary results of its tender offer to purchase up to 5,000,000 shares of its common stock at a price of $34.00 per share, which expired at 5:00 p.m., New York City time, on September 10, 2013. Based on the preliminary count by American Stock Transfer & Trust Company, the Depositary for the tender offer, approximately 28.5 million shares of common stock were tendered and not withdrawn, including: approximately 14 million shares that were tendered through notice of guaranteed delivery; and approximately 2.5 million shares that were conditionally tendered by stockholders and for which the determination whether the applicable conditions were met will be made following the verification process described below. Accordingly, WebMD expects to accept for purchase a total of 5,000,000 shares at a purchase price of $34.00 per share, for an aggregate purchase price of $170 million.  Full Article

MMRGlobal Inc's Subsidiary Terminates Agreement With WebMD
Tuesday, 3 Sep 2013 09:45am EDT 

MMRGlobal, Inc. announced that MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal (collectively, MMR), has terminated the written Agreement it signed with WebMD Health Corp. and WebMD Health Services Group, Inc. (collectively, WebMD) which MMR announced on June 7, 2013, in connection with the dismissal of MMR's patent infringement complaint. MMR is a provider of Personal Health Records (PHRs) and electronic document management and imaging systems for healthcare professionals. The action was originally filed against WebMD on February 11, 2013, in the U. S. District Court for the Central District of California, case number CV 13-00979 (ODW/SHx). As a material inducement for MMR to dismiss its complaint, the parties signed the Agreement setting forth certain terms and conditions including formal negotiations to resolve the matter without the timing constraints imposed by the lawsuit.  Full Article

Webmd Health Corp Announces Commencement Of Tender Offer To Repurchase Up To 5,000,000 Shares Of Common Stock
Monday, 12 Aug 2013 07:15am EDT 

Webmd Health Corp announced that it has commenced a tender offer to purchase up to 5,000,000 shares of common stock at a price of $34.00 per share. The number of shares proposed to be purchased in the tender offer represents approximately 10% of the approximately 50.4 million shares of WebMD Common Stock outstanding as of August 9, 2013 (including shares of unvested restricted stock). The NASDAQ Official Closing Price of WebMD Common Stock on August 9, 2013 was $33.40 per share. The tender offer will expire at 5:00 p.m., New York City time, on September 10, 2013, unless extended by WebMD.  Full Article

Webmd Health Corp Names David J. Schlanger As Chief Executive Officer And Steven L. Zatz As President
Monday, 12 Aug 2013 07:11am EDT 

Webmd Health Corp announced that Board of Directors has appointed David J. Schlanger as Chief Executive Officer of WebMD and Steven L. Zatz, as President. WebMD also announced that Dr. Steven Zatz has been named President of WebMD and will assume responsibility for the Company's consumer and professional websites and services.  Full Article

Webmd Health Corp Announces Intention To Commence Tender Offer To Repurchase Up To 5,000,000 Shares Of Its Common Stock
Tuesday, 6 Aug 2013 04:53pm EDT 

Webmd Health Corp announced that it intends to commence a tender offer within the next week to purchase up to 5,000,000 shares of its common stock at a price per share of $34.00. The number of shares proposed to be purchased in the tender offer represents approximately 10% of WebMD's currently outstanding common shares. The NASDAQ Official Closing Price of WebMD's common stock on August 6, 2013 was $33.14 per share.  Full Article

Search Stocks